Company Overview
- Website
- naveris.com
- Phone
- (833) 628-3747
- Employees
- 89
- Founded in
- 2017
- Industry
- BioTech/Drugs
- SIC Code
-
8731 - Commercial Physical and Biological Research
Financials & Stats
Revenue
$10B
Recent News & Media
Naveris Introduces Advanced NavDx+Gyn™ Test for Early Detection of HPV-Driven Gynecologic Cancers
- Mar 27, 2025
- businesswire.com
Naveris Announces Expansion of the NavDx® Test in Anal Cancer Molecular Residual Disease Surveillance
- Jan 10, 2025
- businesswire.com
Naveris Announces Expanded Commercial Payor Coverage for NavDx® Test from Blue Shield of California
- Oct 9, 2024
- businesswire.com
CMS Designates the NavDx® Test as an Advanced Diagnostic Laboratory Test (ADLT)
- Mar 21, 2024
- businesswire.com
Naveris Announces Commercial Payor Coverage for NavDx® Test from Highmark, Inc.
- Feb 22, 2024
- businesswire.com
Novel HPV Associated Oropharyngeal Squamous Cell Carcinoma Surveillance DNA Assay Cost Analysis
- Apr 18, 2023
- onlinelibrary.wiley.com
Company Leadership
NAVERIS Industry Tags
NAVERIS Tech Stack
Companies Similar to NAVERIS
Analyze industry trends and opportunities by examining competitors and companies comparable to NAVERIS, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
Company Name | Revenue | Number of Employees | Location | Founded in |
---|---|---|---|---|
10M | 59 | Boston, MA | ||
10M | 27 | Cambridge, MA | 2010 | |
10M | 23 | Waltham, MA | 1999 | |
10M | 2 | Boston, MA | ||
10M | 46 | Woburn, MA |